CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 23,897	$ 15,333	$ 45,812	$ 30,613
General and administrative	8,277	6,459	16,784	13,979
Total operating expenses	32,174	21,792	62,596	44,592
Loss from operations	(32,174)	(21,792)	(62,596)	(44,592)
Other income:
Interest income	2,195	133	4,184	196
Total other income	2,195	133	4,184	196
Net loss	$ (29,979)	$ (21,659)	$ (58,412)	$ (44,396)
Net loss per share attributable to common stockholders, basic	$ (0.45)	$ (0.58)	$ (0.88)	$ (1.19)
Net loss per share attributable to common stockholders, diluted	$ (0.45)	$ (0.58)	$ (0.88)	$ (1.19)
Weighted-average number of common shares outstanding, basic	67,033,150	37,437,063	66,651,547	37,365,647
Weighted-average number of common shares outstanding, diluted	67,033,150	37,437,063	66,651,547	37,365,647
Other comprehensive income (loss):
Unrealized gain (loss) on available for sale investments	$ (262)	$ (254)	$ 334	$ (1,326)
Total other comprehensive income (loss)	(262)	(254)	334	(1,326)
Comprehensive loss	$ (30,241)	$ (21,913)	$ (58,078)	$ (45,722)